|
Sign In to gain access to subscriptions and/or personal tools.
|
Therapy in the elderly hypertensive
Peter A Meredith
University Department of Medicine & Therapeutics, The Western Infirmary, Glasgow, UK
Peter Trenkwalder
Starnberg Hospital, Ludwig Maxmilian University, Munich, Germany
The number of people over the age of 65 years continues to increase. In most societies blood pressure (BP) increases with age and elevated levels of BP are common in the elderly.The elderly are also a high-risk group for cardiovascular (CV) disease, which is the leading cause of death in most developed countries. Several intervention trials have confirmed lower CV disease risk in hypertensive patients aged into their early eighties when treated with a variety of antihypertensive drugs. Whilst there is some limited evidence to suggest that -blockers may not be as effective as thiazide diuretics in reducing coronary heart disease (CHD) or total mortality in the elderly, the combination of the two agents and thiazides alone appear to be as effective as newer agents, such as angiotensin-converting enzyme inhibitors (ACE-I) and calcium antagonists. There was no evidence from these trials that BP reduction in the elderly was associated with any deleterious effects.
Whilst the benefits of treating the elderly hypertensive are well established, some issues remain to be clarified, particularly in relation to treating the very elderly and the potential benefits beyond BP control that may be afforded by newer antihypertensive agents.
Key Words: hypertension elderly antihypertensive therapy age cardiovascular risk cost benefit quality of life randomised control trial isolated systolic hypertension
References
- Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Analysis Based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-74.[Abstract/Free Full Text]
- Kannel WB, Gordon T., Schwartz MJ Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1997;27:335-46.[CrossRef]
- The MRFIT Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1988;260:3451-5.[Abstract/Free Full Text]
- Sagie A., Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993;329: 1912-17.[Abstract/Free Full Text]
- ISH. ISH working group report on hypertension in the elderly. Hypertension 1994;23:275-85.[Abstract/Free Full Text]
- O'Donnell CJ, Ridker PM, Glynn RJ et al. Hypertension and borderline isolated systolic hypertension increases risk of cardiovascular disease and mortality in male physicians. Circulation 1997;95:1132-7.[Abstract/Free Full Text]
- Izzo JL, Levy D., Black HR Clinical advisory statement: importance of systolic blood pressure in older Americans. Hypertension 2000;35:1021-4.[Free Full Text]
- Swales JD Current status of hypertensive disease treatment: results from the Evaluation and Interventions for Systolic Blood pressure Elevation: Regional and Global (EISBERG) project. J Hypertens 1999;17(suppl 2):S15-S19.
- Duggan S., Ford GA, Eccles M. Doctors' attitudes towards the detection and treatment of hypertension in older people. J Hum Hypertens 1997;11:271-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-45.[Abstract/Free Full Text]
- Marques-Vidal P., Tuomilheto H. Hypertension awareness, treatment and control in the community: is the `rule of halves` still valid? J Hum Hypertens 1997;11:213-20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Primatesta P., Brookes M., Poulter NR Improved Hypertension Management Control. Results from the Health Survey for England 1998. Hypertension 2001;38:827-32.
- Ménard J., Chantellier G. Limiting factors in the control of BP: why is there a gap between theory and practice? J Hum Hypertens 1995;9:S19-S23.
- MacMahon S., Peto R., Cutler J. Blood pressure, stroke and coronary heart disease: Part I. Prolonged differences in blood pressure, prospective observational studies corrected for regression dilution bias. Lancet 1990;335:765-74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Volkonas PS, Kannel WB, Cupples LA Epidemiology and risk of hypertension in the elderly: The Framingham Study. J Hypertens 1998;6(suppl 1):S3-S9.
- Beckett NS, Fletcher AE, Bulpitt CJ The rationale for the Hypertension in the Very Elderly Trial (HYVET). Eur Heart J Supplements 1999;1(suppl P):P13-P16.[Web of Science]
- Zanchetti A., Hansson L., Dahlof B. et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. J Hypertens 2001;19:1149-59.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- AmeryA., Birkenhäger W., Brixko P. et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the ElderlyTrial. Lancet 1985;1:1349-54.[Web of Science][Medline]
[Order article via Infotrieve]
- MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-12.[Abstract/Free Full Text]
- Dahlöf B., Lindholm LH, Hansson L. et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.[Abstract/Free Full Text]
- Kostis JB, Davis BR, Cutler J. et al. for the SHEP Co-operative Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997;278:212-16.[Abstract/Free Full Text]
- Curb JD, Pressel SL, Cutler JA et al. for the Systolic Hypertension in the Elderly Program Co-operative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension [published correction appears in JAMA 1997;277:1356]. JAMA 1996;276:1886-92.[Abstract/Free Full Text]
- Staessen JA, Fagard R., Thijs L. et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Staessen JA, Lutgarde R., Fagard RH et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Calcium Channel Blockade and Cardiovascular Prognosis in the European Trial on Isolated Systolic Hypertension. Hypertension 1998;32:410-16.[Abstract/Free Full Text]
- Liu L.,Wang JG, Gong L. et al. for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998;16:1823-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Staessen JA, Gasowski J., Wang JG et al. Risks of untreated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-72.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lever AF, Ramsay LE Treatment of hypertension in the elderly. J Hypertens 1995;13:571-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gong L., Zhang W., Zhu Y. et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14:1237-45.[Web of Science][Medline]
[Order article via Infotrieve]
- Hansson L., Lindholm LH, Ekbom R. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999;354:1751-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lindholm LH, Hansson L., Ekbom T. et al. for the STOP Hypertension-2 Study Group. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. J Hypertens 2000;18:1671-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Johannesson M., Dahlof B., Lindholm LH et al. The cost-effectiveness of treating hypertension in elderly people - an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension). J Intern Med 1993; 234:317-23.[Web of Science][Medline]
[Order article via Infotrieve]
- Guidelines Subcommittee. 1999 World Health Organisation-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-83.[Web of Science][Medline]
[Order article via Infotrieve]
- Ramsay LE, Williams B., Johnston GD et al. British Hypertension Society Guidelines for hypertension management 1999: Summary. BMJ 1999;319:630-5.[Free Full Text]
- Whelton PK, Appel LJ, Espeland MA et al. for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomised controlled Trial of Nonpharmacologic interventions in the Elderly (TONE). JAMA 1998;279:839-46.[Abstract/Free Full Text]
- Messerli FH, Grossman E., Goldbourt U.Are beta blockers efficacious as first line therapy for hypertension in the elderly? A systematic review. JAMA 1998;279:1903-07.[Abstract/Free Full Text]
- Dahlöf B., Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hansson L., Lithell H., Skoog I. et al. Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline characteristics. Blood Pressure 2000;9:146-51.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gueyffier F., Bulpitt C., Boissel JP et al. for the INDANA Group. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999;353:793-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Godreuil C., Ollivier JP, Nisse-Durgeat S. Candesartan cilexetil in isolated systolic hypertension study (CASH): Objectives, materials and methods. J Hypertens 2001;19 (suppl 2):S151.
Journal of Renin-Angiotensin-Aldosterone System, Vol. 3, No. 1 suppl,
S49-S56 (2002)
DOI: 10.3317/jraas.2002.031

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|